Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $947000.0.

  • Biomerica's Receivables - Net fell 2858.22% to $947000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $947000.0, marking a year-over-year decrease of 2858.22%. This contributed to the annual value of $731000.0 for FY2025, which is 2280.89% down from last year.
  • Per Biomerica's latest filing, its Receivables - Net stood at $947000.0 for Q4 2025, which was down 2858.22% from $1.2 million recorded in Q3 2025.
  • Over the past 5 years, Biomerica's Receivables - Net peaked at $1.9 million during Q1 2021, and registered a low of $722000.0 during Q2 2023.
  • Over the past 5 years, Biomerica's median Receivables - Net value was $1.1 million (recorded in 2021), while the average stood at $1.1 million.
  • Examining YoY changes over the last 5 years, Biomerica's Receivables - Net showed a top increase of 9516.61% in 2021 and a maximum decrease of 5123.28% in 2021.
  • Over the past 5 years, Biomerica's Receivables - Net (Quarter) stood at $1.1 million in 2021, then fell by 24.46% to $850014.0 in 2022, then rose by 25.53% to $1.1 million in 2023, then grew by 24.27% to $1.3 million in 2024, then fell by 28.58% to $947000.0 in 2025.
  • Its Receivables - Net was $947000.0 in Q4 2025, compared to $1.2 million in Q3 2025 and $731000.0 in Q2 2025.